Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › LENSKART

LENSKART

Lenskart Solutions Limited
Mid-capHealthcare ↗

What the six lenses say about LENSKART — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹546.0
2026-07-10
VWAP · 1Y anchor
₹474
+15.2% from VWAP
P/E · TTM
138.9×
TTM EPS ₹3.9
52-week range
98%
position low→high
RSI(14)
71
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How LENSKART’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD658›

The actual numbers

Price vs VWAP (1y)+15.2%
Price vs 50-EMA+6.2%
RSI(14)71
RS vs Nifty 500 · 3M-3.6%
RS vs sector · 3M-15.2%
52-week range98%
Volume vs 30d avg1.86×
Volume vs 60d avg1.75×
ATR(14) · volatility17.4
Bollinger width · vol contraction0.113
FundamentalD132›

The actual numbers

Return on equity (ROE)6.9%
Return on capital (ROCE)8.4%
Operating margin9.7%
Net margin5.7%
Debt / equity0.35×

Full 8-quarter history in the financials table below.

ValuationD10›

The actual numbers

P/E (TTM)138.9×
TTM EPS₹3.9
52-week range98%
CatalystD331›

The actual numbers

Earnings & momentum23
Capital actions24
Governance73

Every filing in the corporate-announcements panel below.

FlowD550›

The actual numbers

Promoter holding17.6%
Delivery · 30d avg58.7%
Up/down-day asymmetry2.6pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D6 + D5 ) ÷ 2 = 5.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Medium
57
Conviction score 57/100 · avg-decile strength 5.5/10
Conviction score57/100›
TechnicalD6›
FundamentalD1›
ValuationD1›
CatalystD3›
FlowD5›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.4pp
+3.8pp
+5.9pp
+0.1pp
+26.0pp
—
Nifty 500
Broad-market baseline
+1.0pp
+3.7pp
+5.3pp
-3.6pp
+20.9pp
—
Sector
Own-sector index
—
—
+3.6pp
-15.2pp
+8.1pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

LENSKART daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
545.95+9.40

Relative strength

RS vs baseline · rebased to 100

LENSKART ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
138.46+1.36

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)1,7361,6691,7281,8942,0962,3082,516
↳ change QoQ—-3.9%+3.5%+9.6%+10.7%+10.1%+9.0%
EBITDA (₹cr)286210292336413462536
EBITDA margin16.5%12.6%16.9%17.7%19.7%20.0%21.3%
PAT (₹cr)86222061103133204
↳ change QoQ—-97.7%+10900.0%-72.3%+68.9%+29.1%+53.4%
Net margin5.0%0.1%12.7%3.2%4.9%5.8%8.1%
EPS (₹)11.080.022.840.781.240.761.15
D/E———————
YoY growth · Mar '26Revenue +45.6% YoYPAT -7.3% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 15 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 22 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    HIGHgovernance
    Change in Auditors
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    HIGHcapital
    Amalgamation/Merger
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 May '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 May '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 14 May '26
    LOWgovernance
    Monitoring Agency Report
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds LENSKART

Mutual funds holding LENSKART (10)

FundWeightAUM ₹crGrade
HDFC Flexi Cap Gr0.51%1,01,822
Kotak Midcap Reg Gr1.18%67,611
Mirae Asset Large & Midcap Gr1.15%42,792
Aditya BSL Large Cap Gr0.89%28,640
Aditya BSL Large Cap Gr Tr0.89%28,640
Aditya BSL Flexi Cap Gr1.58%26,032
Mirae Asset ELSS Tax Saver Reg Gr1.57%25,374
Canara Robeco Large & Mid Cap Reg Gr1.03%25,251
ICICI Pru Flexicap Reg Gr1.44%21,189
DSP Midcap Reg Gr0.60%19,673

ETFs holding LENSKART (1)

ETFWeightGrade
Motilal Oswal BSE Select IPO ETF1.45%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare